Annual Operating Expenses
$55.73 M
+$4.75 M+9.31%
30 September 2023
Summary:
Anavex Life Sciences annual total operating expenses is currently $55.73 million, with the most recent change of +$4.75 million (+9.31%) on 30 September 2023. During the last 3 years, it has risen by +$13.78 million (+32.86%). AVXL annual operating expenses is now at all-time high.AVXL Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$14.73 M
+$2.68 M+22.26%
30 June 2024
Summary:
Anavex Life Sciences quarterly total operating expenses is currently $14.73 million, with the most recent change of +$2.68 million (+22.26%) on 30 June 2024. Over the past year, it has increased by +$2.08 million (+16.42%). AVXL quarterly operating expenses is now -4.10% below its all-time high of $15.36 million, reached on 31 December 2022.AVXL Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVXL Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +16.4% |
| 3 y3 years | +32.9% | +20.2% |
| 5 y5 years | +93.5% | +134.9% |
AVXL Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +32.9% | -4.1% | +30.4% |
| 5 y | 5 years | at high | +93.5% | -4.1% | +134.9% |
| alltime | all time | at high | >+9999.0% | -4.1% | >+9999.0% |
Anavex Life Sciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $14.73 M(+22.3%) |
| Mar 2024 | - | $12.05 M(+6.7%) |
| Dec 2023 | - | $11.29 M(-10.7%) |
| Sept 2023 | $55.73 M(+9.3%) | $12.65 M(-6.5%) |
| June 2023 | - | $13.53 M(+0.7%) |
| Mar 2023 | - | $13.44 M(-12.5%) |
| Dec 2022 | - | $15.36 M(+0.5%) |
| Sept 2022 | $50.99 M(+21.5%) | $15.28 M(+22.7%) |
| June 2022 | - | $12.46 M(+8.2%) |
| Mar 2022 | - | $11.52 M(-1.7%) |
| Dec 2021 | - | $11.72 M(-4.3%) |
| Sept 2021 | $41.95 M(+35.6%) | $12.25 M(+7.9%) |
| June 2021 | - | $11.36 M(+27.0%) |
| Mar 2021 | - | $8.94 M(-4.8%) |
| Dec 2020 | - | $9.40 M(+25.2%) |
| Sept 2020 | $30.94 M(+7.4%) | $7.51 M(-7.4%) |
| June 2020 | - | $8.11 M(+5.3%) |
| Mar 2020 | - | $7.70 M(+0.9%) |
| Dec 2019 | - | $7.63 M(+21.6%) |
| Sept 2019 | $28.81 M(+50.2%) | $6.27 M(-11.3%) |
| June 2019 | - | $7.07 M(-12.3%) |
| Mar 2019 | - | $8.07 M(+9.0%) |
| Dec 2018 | - | $7.40 M(+27.3%) |
| Sept 2018 | $19.18 M(+23.5%) | $5.81 M(+28.0%) |
| June 2018 | - | $4.54 M(-4.0%) |
| Mar 2018 | - | $4.73 M(+15.7%) |
| Dec 2017 | - | $4.09 M(-21.0%) |
| Sept 2017 | $15.54 M(+0.6%) | $5.18 M(+42.4%) |
| June 2017 | - | $3.64 M(+1.2%) |
| Mar 2017 | - | $3.59 M(+14.6%) |
| Dec 2016 | - | $3.13 M(-52.2%) |
| Sept 2016 | $15.45 M(+117.3%) | $6.56 M(+191.9%) |
| June 2016 | - | $2.25 M(+4.3%) |
| Mar 2016 | - | $2.15 M(-45.1%) |
| Dec 2015 | - | $3.92 M(-1.1%) |
| Sept 2015 | $7.11 M(+139.4%) | $3.97 M(+162.2%) |
| June 2015 | - | $1.51 M(+76.3%) |
| Mar 2015 | - | $858.30 K(+11.4%) |
| Dec 2014 | - | $770.70 K(+20.5%) |
| Sept 2014 | $2.97 M | $639.40 K(-36.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $998.80 K(-2.2%) |
| Mar 2014 | - | $1.02 M(+229.8%) |
| Dec 2013 | - | $309.60 K(-78.9%) |
| Sept 2013 | $2.14 M(-50.5%) | $1.47 M(+1065.4%) |
| June 2013 | - | $126.00 K(-0.9%) |
| Mar 2013 | - | $127.10 K(-69.4%) |
| Dec 2012 | - | $415.40 K(-35.2%) |
| Sept 2012 | $4.32 M(-30.1%) | $641.40 K(-7.9%) |
| June 2012 | - | $696.30 K(-12.4%) |
| Mar 2012 | - | $794.70 K(-63.7%) |
| Dec 2011 | - | $2.19 M(+78.6%) |
| Sept 2011 | $6.17 M(+9.3%) | $1.22 M(-25.1%) |
| June 2011 | - | $1.63 M(-16.0%) |
| Mar 2011 | - | $1.95 M(+42.3%) |
| Dec 2010 | - | $1.37 M(-30.4%) |
| Sept 2010 | $5.65 M(+19.3%) | $1.96 M(+50.7%) |
| June 2010 | - | $1.30 M(-14.1%) |
| Mar 2010 | - | $1.52 M(+72.4%) |
| Dec 2009 | - | $880.00 K(-51.1%) |
| Sept 2009 | $4.73 M(-10.2%) | $1.80 M(+43.3%) |
| June 2009 | - | $1.26 M(+63.2%) |
| Mar 2009 | - | $770.00 K(-15.0%) |
| Dec 2008 | - | $905.80 K(-66.3%) |
| Sept 2008 | $5.27 M(+234.0%) | $2.69 M(+169.9%) |
| June 2008 | - | $995.00 K(+48.1%) |
| Mar 2008 | - | $671.70 K(-32.0%) |
| Dec 2007 | - | $987.50 K(-13.4%) |
| Sept 2007 | $1.58 M(+6063.7%) | $1.14 M(+346.3%) |
| June 2007 | - | $255.60 K(+51.4%) |
| Mar 2007 | - | $168.80 K(+1272.4%) |
| Dec 2006 | - | $12.30 K(+112.1%) |
| Sept 2006 | $25.60 K(-72.1%) | $5800.00(+1.8%) |
| June 2006 | - | $5700.00(+21.3%) |
| Mar 2006 | - | $4700.00(-50.0%) |
| Dec 2005 | - | $9400.00(-77.6%) |
| Sept 2005 | $91.70 K(+532.4%) | $42.00 K(-8.1%) |
| June 2005 | - | $45.70 K(0.0%) |
| Mar 2005 | - | $45.70 K(+1014.6%) |
| Dec 2004 | - | $4100.00 |
| Sept 2004 | $14.50 K | - |
FAQ
- What is Anavex Life Sciences annual total operating expenses?
- What is the all time high annual operating expenses for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly operating expenses year-on-year change?
What is Anavex Life Sciences annual total operating expenses?
The current annual operating expenses of AVXL is $55.73 M
What is the all time high annual operating expenses for Anavex Life Sciences?
Anavex Life Sciences all-time high annual total operating expenses is $55.73 M
What is Anavex Life Sciences quarterly total operating expenses?
The current quarterly operating expenses of AVXL is $14.73 M
What is the all time high quarterly operating expenses for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly total operating expenses is $15.36 M
What is Anavex Life Sciences quarterly operating expenses year-on-year change?
Over the past year, AVXL quarterly total operating expenses has changed by +$2.08 M (+16.42%)